Xifaxan 550 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FQW82
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,054
Award facts
- Contract value 100% obligated
- $2,053.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,053.56 delivery order to AmerisourceBergen Drug Corp for Xifaxan 550 mg tablets (60-count) on May 30, 2025, with an ultimate completion date of June 2, 2025. This firm fixed price, non-set-aside contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to distribute a broad range of medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, one of the nation's major pharmaceutical distributors, serves as a critical federal medical procurement vendor for military and veteran healthcare systems through competitively awarded contracts. The company's extensive federal contract portfolio encompasses specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains, with awards consistently structured as delivery orders under firm fixed pricing arrangements. This particular order for Xifaxan, an antibiotic treatment, exemplifies the routine pharmaceutical supply deliveries that AmerisourceBergen fulfills through its DLA prime vendor relationship to support the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FQW82?
SPE2DB25FQW82 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FQW82 worth?
The government has obligated $2,054 on SPE2DB25FQW82.
Is contract SPE2DB25FQW82 an order under another contract?
Yes. SPE2DB25FQW82 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQW82 competed?
The extent of competition for SPE2DB25FQW82 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award